These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 17657989)
1. [Problems of cortisol assay: confusion in the diagnosis of preclinical Cushing's syndorme]. Odagiri E; Naruse M; Tanabe A; Ohmura M; Oki T; Katabami T; Saitoh J; Nishika T; Shibata H; Doi M; Hirata Y Rinsho Byori; 2007 Jun; 55(6):549-54. PubMed ID: 17657989 [TBL] [Abstract][Full Text] [Related]
2. The diagnostic standard of preclinical Cushing's syndrome: evaluation of the dexamethasone suppression test using various cortisol kits. Odagiri E; Naruse M; Terasaki K; Yamaguchi N; Jibiki K; Takagi S; Tanabe M; Takano K Endocr J; 2004 Jun; 51(3):295-302. PubMed ID: 15256774 [TBL] [Abstract][Full Text] [Related]
3. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome. Castro M; Elias LL; Elias PC; Moreira AC Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925 [TBL] [Abstract][Full Text] [Related]
4. [Clinical aspect of adrenal incidentaloma]. Miyamori I Nihon Rinsho; 2004 May; 62(5):925-8. PubMed ID: 15148820 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis of canine Cushing's syndrome based on multiple steroid analysis and dexamethasone turnover kinetics. Lothrop CD; Oliver JW Am J Vet Res; 1984 Nov; 45(11):2304-9. PubMed ID: 6098199 [TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and differential diagnosis of Cushing's syndrome]. Penezić Z; Zarković M; Vujović S; Drezgić M Srp Arh Celok Lek; 2006; 134(11-12):558-66. PubMed ID: 17304774 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of endocrine tests. B: screening for hypercortisolism. Holleman F; Endert E; Prummel MF; van Vessem-Timmermans M; Wiersinga WM; Fliers E Neth J Med; 2005 Oct; 63(9):348-53. PubMed ID: 16244382 [TBL] [Abstract][Full Text] [Related]
13. [Test of pituitary adrenal suppressibility with I.V. dexamethsaone in the diagnosis of Cushing's syndrome (author's transl)]. Linquette M; Cappoen JP; Fourlinnie JC; Harpignies G Pathol Biol (Paris); 1980 Feb; 28(2):85-9. PubMed ID: 7005835 [TBL] [Abstract][Full Text] [Related]
14. In the overnight dexamethasone suppression test, 1.0 mg loading is superior to 0.5 mg loading for diagnosing subclinical adrenal Cushing's syndrome based on plasma dexamethasone levels determined using liquid chromatography-tandem mass spectrometry. Sasaki Y; Katabami T; Asai S; Fukuda H; Tanaka Y Endocr J; 2017 Sep; 64(9):833-842. PubMed ID: 28637948 [TBL] [Abstract][Full Text] [Related]
15. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states. Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996 [TBL] [Abstract][Full Text] [Related]
16. An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism. Friedman TC Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):356-60. PubMed ID: 16915537 [TBL] [Abstract][Full Text] [Related]
17. Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders. Restituto P; Galofré JC; Gil MJ; Mugueta C; Santos S; Monreal JI; Varo N Clin Biochem; 2008 Jun; 41(9):688-92. PubMed ID: 18280810 [TBL] [Abstract][Full Text] [Related]